I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Okusanya, Olanrewaju O.
76
results:
Search for persons
X
Format
Online (76)
Mediatypes
Articles (Online) (62)
Bookchapter (Online) (1)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
FDA Approval Summary: Selinexor for Relapsed or Refractory ..:
Kasamon, Yvette L.
;
Price, Lauren S.L.
;
Okusanya, Olanrewaju O.
...
The Oncologist. 26 (2021) 10 - p. 879-886 , 2021
Link:
https://doi.org/10.1002/..
?
2
A Simulation Approach to Evaluate the Impact of Patterns of..:
Obianom, Obinna N.
;
Okusanya, Olanrewaju O.
;
Earp, Justin
.
Clinical Pharmacology & Therapeutics. 108 (2020) 1 - p. 107-115 , 2020
Link:
https://doi.org/10.1002/..
?
3
Application of Pharmacokinetic-Pharmacodynamic Modeling and..:
Tsuji, Brian T.
;
Okusanya, Olanrewaju O.
;
Bulitta, Jurgen B.
...
Clinical Infectious Diseases. 52 (2011) - p. S513-S519 , 2011
Link:
https://www.jstor.org/st..
?
4
Evaluation of the pharmacokinetics–pharmacodynamics of fusi..:
Okusanya, Olanrewaju O.
;
Tsuji, Brian T.
;
Bülitta, Jurgen B.
...
Diagnostic Microbiology and Infectious Disease. 70 (2011) 1 - p. 101-111 , 2011
Link:
https://doi.org/10.1016/..
?
5
Application of Pharmacokinetic-Pharmacodynamic Modeling and..:
Tsuji, Brian T.
;
Okusanya, Olanrewaju O.
;
Bulitta, Jurgen B.
...
Clinical Infectious Diseases. 52 (2011) suppl_7 - p. S513-S519 , 2011
Link:
https://doi.org/10.1093/..
?
6
Use of pharmacodynamic endpoints for the evaluation of levo..:
Ambrose, Paul G.
;
Anon, Jack B.
;
Bhavnani, Sujata M.
...
Diagnostic Microbiology and Infectious Disease. 61 (2008) 1 - p. 13-20 , 2008
Link:
https://doi.org/10.1016/..
?
7
FDA Approval Summary: Belumosudil For Adult and Pediatric P..:
Przepiorka, Donna
;
Le, Robert Q
;
Ionan, Alexei
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197942/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
FDA Approval Summary: Belantamab Mafodotin for Patients wit..:
Baines, Andrea C
;
Ershler, Rachel
;
Kanapuru, Bindu
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633344/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
9
FDA approval summary: decitabine and cedazuridine tablets f..:
Kim, Nina
;
Norsworthy, Kelly J
;
Subramaniam, Sriram
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378483/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
FDA Approval Summary: Revised Indication and Dosing Regimen..:
Pulte, E Dianne
;
Chen, Haiyan
;
Price, Lauren S L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895737/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin a..:
Bulik, Catharine C
;
Okusanya, Ólanrewaju O
;
Lakota, Elizabeth A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278741/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
12
Exploration of the Pharmacokinetic-Pharmacodynamic Relation..:
VanScoy, Brian D
;
McCauley, Jennifer
;
Ellis-Grosse, Evelyn J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649205/. , 2015
Link:
http://www.ncbi.nlm.nih...
?
13
Evaluation of the Pharmacokinetics and Pharmacodynamics of ..:
Okusanya, Olanrewaju O
;
Bhavnani, Sujata M
;
Hammel, Jeffrey P
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014
Link:
http://www.ncbi.nlm.nih...
?
14
Pharmacological Basis of β-Lactamase Inhibitor Therapeutics..:
VanScoy, Brian
;
Mendes, Rodrigo E
;
McCauley, Jennifer
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2013
Link:
http://www.ncbi.nlm.nih...
?
15
Relationship between Ceftolozane-Tazobactam Exposure and Dr..:
VanScoy, Brian
;
Mendes, Rodrigo E
;
Castanheira, Mariana
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754319. , 2013
Link:
http://www.ncbi.nlm.nih...
1-15